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NC-ND license (http://creativecommoSummary We report a case of pseudolymphoma of the liver in a 49-year-old womanwithout an
underlying disease except for liver hemangioma. A 20-mm nodule was incidentally found in
segment 2 of the liver by abdominal ultrasonography during a regular follow-up of the hepatic
hemangioma. After a series of radiological examinations, a left lateral sectionectomy was per-
formed becausemalignant hepatic tumor could not be excluded. The patient was discharged un-
eventfully 7 days after the operation. The pathology examination revealed a pseudolymphoma.
No recurrence of the tumor was found 5½ years after the operation. To the best of our knowl-
edge, only 46 cases of pseudolymphoma of the liver have been reported to date. A review of
the literature showed that pseudolymphomas occur predominantly in females (89.4%), usually
occur as a single tumor (80.4%), are nomore than 20mm in size (90.6%), and are frequently asso-
ciated with either autoimmune disease or chronic liver disease. Because an accurate diagnosis is
difficult to establish, vigilant follow-up is indicated, and surgical intervention is the choice of
treatment once the suspiciousness of malignancy has been raised.
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Hepatic pseudolymphoma 751. Introduction
Pseudolymphoma (also referred to as reactive lymphoid
hyperplasia or nodular lymphoid lesion) of the liver is a rare
benign nonspecific lesion characterized by a marked pro-
liferation of polyclonal lymphocytes forming follicles with
an active germinal center.1 Even though the etiology and
pathogenesis of pseudolymphomas are unknown, their as-
sociation with chronic infection or inflammatory process
suggests their correlation with immunological response.2 In
addition, their association with malignancy has been re-
ported. The preoperative diagnosis for pseudolymphoma is
difficult because noninvasive radiologic imaging findings are
usually equivocal. We describe a case of pseudolymphoma
and review the literature to reveal the clinicopathological
characteristics of this particular disease entity.
2. Case report
A 49-year-old woman who had a hepatic hemangioma noted
since 1995 underwent an annual routine medical examina-
tion. The abdominal ultrasonography showed a hypoechoic
lesion, about 20  16  14 mm in size, located in segment 2
of the liver in 2007. Laboratory tests revealed no elevation
of hepatic enzymes (aspartate aminotransferase, 17 IU/L;
alanine aminotransferase, 13 IU/L; alkaline phosphatase,
141 IU/L; gamma-glutamyltranspeptidase, 22 IU/L) and a
normal lactate dehydrogenase level. Hepatitis B virus sur-
face antigen and hepatitis C virus antibody were both
negative. In addition, the levels of tumor markers including
a-fetoprotein, carcinoembryonic antigen, and carbohy-
drate antigen 19-9 were all within the normal limits. The
corresponding computed tomography (CT) scans revealed a
relatively hypodense solid lesion with peripheral rim
enhancement in arterial and portal venous phases (Fig. 1A
and B). Magnetic resonance (MR) imaging showed hypo-
intensity in axial T1-weighted images (Fig. 1C) and
hyperintensity in axial T2-weighted images (Fig. 1D). Post-
gadolinium enhancement corresponded with the CT images.
CT arterial portography demonstrated a perfusion defect in
segment 2 of the liver. However, this small segment 2 tumor
had no definite tumor stain on angiography study. A hypo-
vascular tumor was impressed, and peripheral type
cholangiocarcinoma, metastatic tumor, or sclerosed hem-
angioma should be differentiated. A left lateral sectio-
nectomy was performed in March 2007. The patient had an
uneventful postoperative course and was discharged on the
7th postoperative day.
Grossly, the lesion was a well-defined, nonencapsulated,
yellowish-white, and firm mass measuring 20  15 
15 mm, just beneath the capsule of the liver (Fig. 2) with a
satellite lesion about 3 mm in size near the previous lesion.
Hematoxylineeosin-stained histological images showed
that the tumor was composed of lymphoid hyperplasia with
several enlarged, irregularly shaped, well-demarcated
follicles with formation of germinal centers. The lympho-
cytes containing round nuclei with scant cytoplasm were
mainly small in size and mature in appearance with scat-
tered medium and large cells (Fig. 3A). Tangible body
macrophages were discernible. Immunohistochemical stain
revealed that the follicles were composed of CD20 (þ), Bcl-2 (e) B cells (Fig. 3B and C), and the interfollicular area was
composed of CD3 (þ) small T cells (Fig. 3D). Reactive CD30
(þ) immunoblasts were evenly distributed in the inter-
follicular region (Fig. 3E). The EBER (EpsteineBarr virus-
encoded RNA) stain was negative (Fig. 3F). The whole pic-
ture favored a diagnosis of pseudolymphoma. In addition,
the satellite nodule showed similar pictures. The patient
received regular follow-up, and no recurrence was found
during 5½ years of follow-up.3. Discussion
Pseudolymphoma was first described in the lung by Salt-
zstein in 19633 as a lymphocytic tumor associated with
inflammation and with no evidence of systemic dissemina-
tion. Pseudolymphoma of the liver was first reported by
Snover et al4 in 1981. This lymphoproliferative condition is
also referred to as reactive lymphoid hyperplasia or nodular
lymphoid lesion. Pseudolymphomas can be found in the
gastrointestinal tract,5 orbit,6 and pancreas,7 but rarely in
the liver. Based on a review of the PubMed database from
1981 to 2012 using the keywords “pseudolymphoma” and
“lymphoid hyperplasia of the liver”, we found 64 lesions in
46 cases of pseudolymphoma (Table 1),1,2,4,8e41 and most of
the reports (37 reports, 80.4%) dealt with a single tumor.
Interestingly, most of the cases (69.6%) were reported in
Japan. However, whether this is attributable to racial/
ethnic differences or lifestyle factors such as sashimi intake
was not clear. When our case was included, the average
age of the patients was 56.7 years (range Z 15e85,
median Z 58) with female predominance (F/M Z 42:5,
89.3%). The average size of the tumor was 15.1  10.6 mm
(range, 1e60), and most of the tumors (90.6%) were no
more than 20 mm. Some of the patients presented with
extrahepatic autoimmune disease [Sjo¨gren’s syndrome in 1
case; autoimmune thyroiditis in 3 cases; Takayashu aortitis
with antiphospholipid syndrome in 1 case; calcinosis, Ray-
naud’s phenomenon, esophageal dysmotility, sclerodactyly,
telangiectasia (CREST) syndrome in 1 casedrepresenting a
total of 12.8%]. Therefore, a relationship between pseu-
dolymphoma of the liver and immunologic dysregulation
was suggested.40 Many of the patients were found to have
chronic liver disease (primary biliary cirrhosis in 6 cases,
viral hepatitis in 5 cases, nonalcoholic steatohepatitis in 2
cases, representing a total of 35.1%). Pseudolymphomas
have been reported to develop after interferon treatment
for chronic hepatitis.26 These findings support the inflam-
matory nature of the lesion. More importantly, many of the
patients had an accompanying malignancy [colon cancer in
4 cases, gastric cancer in 3 cases, triplicate carcinomas
(gastric, cecal, and colon cancer) in 1 case, renal cell
carcinoma in 3 cases, ovarian cancer in 1 case, and
pancreatic cancer in 1 case, representing a total of 27.7%].
Therefore, immunoreaction again carcinoma cells might
relate to the development of pseudolymphoma.32 Other
associated diseases include diabetes mellitus, hyperten-
sion, and diverticulitis. Interestingly, decreasing size in
pseudolymphoma had been reported.23,40 This phenomenon
might reflect the benign behavior of this particular tumor.
To date, the pathophysiology of pseudolymphoma has not
been understood.
Figure 2 Pathological findings of the lesion. Gross pathologic
specimen revealed a well-defined, nonencapsulated,
yellowish-white, and soft hepatic tumor, located just beneath
the capsule in segment 2 of the liver.
Figure 1 Image findings of the lesion. (A) Abdominal computed tomography (CT) scans showed a 20-mm-diameter, slightly
hypodense mass with peripheral rim enhancement in arterial phase located in segment 2. (B) Early washout of the contrast medium
with retained ring enhancement was seen in the portal phase. (C) Axial magnetic resonance (MR) imaging showed a hypointense
nodule on segment 2 of the liver in the T1-weighted image, and (D) the lesion became hyperintense in the T2-weighted image. (E)
Arterial portography with computed tomography demonstrated a perfusion defect in segment 2 of the liver. Angiography showed a
hypervascular lesion on segment 6 of the liver (arrow). (F) However, the small tumor in segment 2 of the liver on previous CT and MR
had no definite tumor stain.
76 C.-T. Yang et al.Based on previously reported cases, in terms of preop-
erative imaging findings, most of the lesions are depicted as
hypoechoic lesions on ultrasound with or without well-
defined margins27 and having a low density on plain CT but
variable density in contrast CT.2,41 MR imaging showed
nonspecific signal intensity and angiography did not show
tumor stain.41 In our patient, there were no risk factors for
hepatocellular carcinoma, and the liver was not cirrhotic
and the a-fetoprotein level was normal. The corresponding
CT and MR images showed a solitary tumor in segment 2 of
the liver with peripheral enhancement. The metastatic
tumor or cholangiocarcinoma should be suspected first.
Common benign tumors such as hemangiomas or focal
nodular hyperplasias were not likely. Because the malig-
nancy could not be excluded, the preoperative biopsy was
an essential tool to establish a final diagnosis.2 However,
for fear of needle implantation of malignant tumor cells,
the patient decided to receive a left lateral sectionectomy
Figure 3 Histopathology of hepatic pseudolymphoma. Hematoxylineeosin-stained histological images showed that the mass was
composed of hyperplastic lymphoid tissue with several enlarged, irregularly shaped, well-demarcated follicles with formation of
germinal centers distributed evenly in the mass. (A) The lymphocytes containing round nuclei with scant cytoplasm are mainly
small in size and mature in appearance with scattered medium and large cells, 40. Immunohistochemical stain showed that the
germinal centers were composed of B lymphocytes (B) positive to CD20 antibody, 100, (C) but negative to Bcl-2 (e) antibody,
100. (D) The interfollicular area was composed of small T lymphocytes positive to CD3 antibody, 100. (E) Reactive immunoblasts
positive to CD30 antibody were evenly distributed in the interfollicular region, 100. (F) However, the EpsteineBarr virus-encoded
RNA stain was negative, 40.
Hepatic pseudolymphoma 77without a biopsy. Our study, consistent with literature re-
ports, shows that it is difficult to preoperatively distinguish
pseudolymphomas from malignant tumors and metastases
on the basis of radiological findings.2,41 In fact, accurate
preoperative diagnosis proved difficult and was achieved
in only three patients,23,27,40 whereas the most frequent
diagnosis before operation was malignancy (80.0%)
including hepatocellular carcinoma in 12 cases, metastatic
tumor in 12 cases, and malignant tumor in four cases (3 of
uncertain nature and 1 of lymphoma).
Histologically, pseudolymphomas consist of hyperplastic
lymphoid follicles, lymphocytes, and other inflammatory
cells, and an accurate diagnosis of pseudolymphoma relies
on immunohistochemical analysis. Usually, immunohisto-
chemical staining showed positive for CD3, CD4, CD8(T markers), and CD20 and CD79a (B cell markers), which
indicated the polyclonality of the tumor. However, staining
for Bcl-2, IgG4, ALK, and SMA was negative.41 Furthermore,
CD3-positive cells were mainly localized in the parafollicular
area and CD20 immunostaining was positive for B follicles,
whereas Bcl-2 staining was negative, indicating the pseu-
dolymphoma’s reactive and nonneoplastic nature.38 In
accordance with these findings, in our case, the immuno-
histochemical stain showed that the follicles were composed
of CD20 (þ), Bcl-2 (e) B cells, and the interfollicular area
was composed of CD3 (þ) small T cells. Moreover, reactive
CD30 (þ) immunoblasts were evenly distributed in the
interfollicular region, and the EBER stain was negative.
Even though their precise etiology and pathogenesis
remain unknown, pseudolymphomas have a much better
Table 1 Reported cases in the literature (including our case).
Case Author(s) Age Sex Tumor
number
Tumor size
(mm)
Preoperative
diagnosis
Treatment Associated disease
1 Snover et al4 15 F 1 N/A Cirrhosis N/A Primary immunodeficiency
2 Tanabe et al9 30 F 1 15 Unknown Resection Acute enteritis
3 Jime´nez et al10 34 F 1 27 Not reported Resection Nil
4 Willenbrock
et al11
36 F 1 18 N/A N/A Focal nodular hyperplasia
of the liver, hemangioma
5 Endou et al8 38 F 1 18 N/A N/A Pancytopenia
6 Zen et al40 40 M 1 20 N/A Resection Chronic hepatitis B
7 Ohtsu et al12 42 F 3 14, 15, and
smaller
HCC Resection Hepatitis B
8 Lin13 44 F 1 15 Metastatic tumor Resection Colon cancer
9 Park et al14 46 F 1 10 Metastatic tumor Resection Renal cell carcinoma,
Hepatitis B
10 Nagano et al15 47 F 1 17 HCC Resection Autoimmune thyroiditis
11 Fukuo et al34 47 F 2 5, 15 HCC or
inflammatory
pseudotumor
Resection Primary biliary cirrhosis
12 Okubo et al16 49 F 1 20 Suspected HCC Resection Sjogren’s syndrome
13 Mori et al17 49 F 1 18 N/A N/A Hepatitis B
14 Shiozawa et al18 51 F 1 20 N/A N/A Nil
15 Sharifi et al1 52 F 1 4 Primary biliary
cirrhosis
Transplantation Primary biliary cirrhosis
16 Machida et al21 53 F 3 10, 12 and 15 HCC Resection Autoimmune thyroiditis
17 Sharifi et al1 56 F 1 15 Primary biliary
cirrhosis
Transplantation Primary biliary cirrhosis
CREST syndrome
18 Sharifi et al1 56 M 1 7 Not reported Resection Diverticulitis
19 Hayashi et al37 56 F 1 15 Metastatic tumor
or HCC
TAE, resection Nonalcoholic fatty liver
disease
20 Fujinaga et al19 58 F 1 15 N/A N/A Hypertension
21 Nichijima et al20 58 F 1 12 N/A N/A Hypertension, diabetes
mellitus
22 Yoshikawa et al41 58 F 1 8 Metastatic tumor Resection Gastric cancer
23 Domı´nguez-Pe´rez
et al35
58 F 1 10 Malignancy,
premalignancy
Resection Primary biliary cirrhosis
24 Marchetti et al38 58 F 1 12 Metastatic tumor Resection Ovarian cancer
25 Isobe et al22 59 F 1 9 Malignant tumor Resection Diabetes mellitus
26 Domı´nguez-Pe´rez
et al35
59 F 1 20 HCC Transplantation Advanced liver cirrhosis
27 Osame et al39 60 F Multiple 5, 5, 6, 6, 7,
8, 10, 10, 35,
60, and
several tiny
ones
Metastatic tumor Resection Renal cell carcinoma
28 Yoshikawa et al41 61 F 1 NA Metastatic tumor Resection GIST
29 Yoshikawa et al41 62 F 1 4 Metastatic tumor Resection Pancreatic cancer
30 Ota et al23 63 F 1 16 Reactive lymphoid
hyperplasia
Observation Nil
31 Okada et al24 63 F 2 4, 13 HCC Resection Primary biliary cirrhosis,
primary aldosteronism
32 Zen et al40 63 F 2 5, 9 Reactive lymphoid
hyperplasia
Resection Primary biliary cirrhosis
Autoimmune thyroiditis
Adrenocortical adenoma
33 Takahashi et al2 64 F 1 10 HCC Resection Colon cancer
34 Zen et al40 64 F 2 10, 35 N/A Biopsy Takayasu aortitis
Antiphospholipid
syndrome
(continued on next page)
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Table 1 (continued )
Case Author(s) Age Sex Tumor
number
Tumor size
(mm)
Preoperative
diagnosis
Treatment Associated disease
35 Katayanagi
et al25,40
66 F 1 15 Suspected
lymphoma
Resection Diabetes mellitus
Nonalcoholic
steatohepatitis
36 Tanizawa et al26 67 F 1 20 HCC Resection Nil
37 Matsumoto
et al27
67 F 1 12 Reactive lymphoid
hyperplasia
Ethanol
injection
Hypertension
38 Kobayashi et al36 68 F 1 10 Pseudotumor or
metastatic tumor
Resection Colon cancer
39 Pantanowitz
et al28
69 F 1 17 Metastatic tumor Resection Renal cell carcinoma
40 Okuhama et al29 70 M 1 40 HCC Resection Nil
41 Maehara et al30 72 F 1 15 MALT lymphoma Resection Nil
42 Kim et al31 72 M 1 17 HCC Resection Gastric cancer,
hepatitis C
43 Sato et al32 75 F 2 14, 20 Metastatic tumor Resection Gastric cancer, cecal
cancer, colon cancer
44 Takahashi et al2 77 F 1 15 Metastatic tumor Resection Colon cancer
45 Zen et al40 81 M 1 55 N/A Biopsy Cholecystolithiasis
46 Grouls33 85 F 2 8, 14 N/A Autopsy Gastric cancer
47 Our case 49 F 2 20, 3 Malignant tumor Resection Hepatic hemangioma
CREST Z calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia; GIST Z gastrointestinal stromal
tumor; HCC Z hepatocellular carcinoma; MALT Z mucosa associated lymphoid tissue; N/A Z not available; TAE Z transarterial
embolization.
Hepatic pseudolymphoma 79prognosis than malignant lymphomas. Treatment methods
for the 40 patients were recorded: resection in 32 cases
(80.0%), liver transplantation in three cases, biopsy in two
cases, ethanol injection in one case, autopsy in one case,
and observation in one case. Ten of the 47 cases have
multiple tumors (21.3%) and only one case had more than
three tumors.39 Furthermore, our case was the second case
associated with hepatic hemangioma,11 and the patient
survived well 5½ years after the operation without tumor
recurrence.
In conclusion, pseudolymphoma of the liver should be
considered in the differential diagnosis of small hepatic
tumors ( 20 mm), especially when a single hypovascular
tumor is found in a female patient and the patient has no
risk factors of hepatocellular carcinoma. Because it is
difficult to preoperatively distinguish pseudolymphomas
from malignant tumors and metastases on the basis of
radiological findings, vigilant follow-up of patients is
essential and surgical intervention is the choice of treat-
ment once the suspiciousness of malignancy has been
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